The New Liver Health Era
Rising metabolic disease, fatty liver, and GLP-1 treatment require earlier liver assessment and continuous monitoring for better outcomes.
MASLD / Fatty Liver
A growing metabolic health burden requiring earlier detection and structured follow-up.
GLP-1 & Metabolic Care
Supporting liver fat monitoring alongside modern weight management and metabolic treatment.
Preventive Screening
Non-invasive liver assessment for check-up, wellness, and early risk identification.
Clinical Validation Highlights
LiverScan AI-POC-TE was clinically validated in a prospective study involving 138 biopsy-confirmed patients and an additional 1,455 paired transient elastography comparisons against conventional FibroScan. The system demonstrated excellent diagnostic performance for both liver fibrosis and steatosis assessment
138 biopsy-confirmed
patients
AUROC 0.92
for ≥S1
Steatosis
Detection
AUROC 0.97
for F4
Cirrhosis
Detection
Validated
in 1,455 Comparative Examinations
Why LiverScan?
Advanced technology designed for accurate, easy, and efficient liver assessment.
B-mode Guided Measurement
Real-time image guidance helps ensure accurate targeting and depth adjustment during liver assessment.
AI-assisted Quality Control
AI algorithms support reliable results through automated signal analysis and quality control.
LSM + MAP in One Workflow
Measure liver stiffness for fibrosis and attenuation parameter for steatosis in a single workflow.
Portable Point-of-Care Design
Wireless, lightweight, and easy to use across hospital, clinic, wellness, and screening settings.
Future of AI-Enabled Liver Assessment
SERVICES ARE AVAILABLE TO USERS 24/7
FDA 510(k) CLEARED
K242496, K233401
Class II Medical Device
PUBLISHED IN
LIVER INTERNATIONAL 2026
Peer-reviewed clinical study
AI-POC-TE PLATFORM
B-mode guided. AI-powered
Real-time results.
DISTRIBUTED BY
ZEST-MED THAILAND
Offcical partner in Thailand
MakeWebEasy